Elena Toschi M.D.

Dr. Toschi received her M.D. from the University of Pisa, Italy. She worked as a post-doc in Susan Bonner-Weir's lab at the Joslin Diabetes Center focusing on islet replication and regeneration. She trained in internal medicine at St. Elizabeth's Medical Center residency program in Boston followed by training at BIDMC/Joslin Endocrinology Fellowship Program.

In the clinic, she sees patients with T1D in different stages of their lives and their disease, and helps them to work on glucose control and manage complications. She is an expert in the use of new technologies such as insulin pumps, continuous glucose monitoring (CGM), insulin pen-caps, and a web-based nutrition application. She is responsible for the Joslin Diabetes Technology Program.

She has been involved in multi-center clinical trials evaluating effectiveness of CGM in Type 1 and Type 2 Diabetes on multiple daily injections (MDI), safety of bolus insulin based on CGM data with or without self-monitoring blood glucose (SMBG), and the development of a mobile app to help manage diabetes. She is an investigator on the only online registry for Type 1 diabetes in the US, as well as industry-sponsored trials examining the effectiveness of new insulin in continuous subcutaneous insulin infusion.